Shilpa Biologicals join hands with Mylab to enter in vaccine and personalised therapeutics business
Shilpa Biologicals join hands with Mylab to enter in vaccine and personalised therapeutics business

Shilpa Biologicals join hands with Mylab to enter in vaccine and personalised therapeutics business

Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Ltd, has announced a strategic tie-up with Mylab Discovery Solutions, India’s leading diagnostic solutions provider.

Sayali Kotwal Article rating: 5.0

Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Ltd, has announced a strategic tie-up with Mylab Discovery Solutions, India’s leading diagnostic solutions provider. With this association, Shilpa Medicare expects to venture into the vaccine and therapeutics segment

DSIJ MINDSHARE

Mkt Commentary18-Jul, 2024

Penny Stocks18-Jul, 2024

Multibaggers18-Jul, 2024

Bonus and Spilt Shares18-Jul, 2024

Swing Trading18-Jul, 2024

Knowledge

General9-Jul, 2024

General9-Jul, 2024

General9-Jul, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR